Table 1.

Demographic and clinical characteristics of our BC patient cohort

Patient IDSexAgeSurgical procedureDisease gradeDisease stageTreatment historyVolume of urineLive cells in urine
Male 74 TURBT High-grade UC NMI, papillary Ta Naïve 50 ml 64.5 × 10e6 
Male 90 TURBT High-grade UC NMI, papillary Ta Naïve 50 ml 72 × 10e6 
Male 75 TURBT High-grade UC NMI, papillary T1 Naïve 95 ml 7 × 10e6 
Male 82 Cystectomy High-grade UC with 20% squamous differentiation MI, papillary T3a Naïve 100 ml 149 × 10e6 
Male 82 Cystectomy Small cell carcinoma (70%), squamous cell (20%), sarcomatoid carcinoma (9%), high-grade UC (1%) MI, papillary T3b BCG 25 ml 31.8 × 10e6 
Male 70 Cystectomy High-grade UC with squamous differentiation MI Naïve 90 ml 55 × 10e6 
Male 64 TURBT High-grade UC with squamous differentiation MI Pre-/post-chemotherapy treatment 60 ml; 65 ml 33 × 10e6; 56 × 10e6 
Male 62 Cystectomy High-grade UC NMI, carcinoma in situ Naïve 30 ml 2.6 × 10e6 
Female 63 TURBT High-grade UC NMI Naïve 65 ml 1.66 × 10e6 
Patient IDSexAgeSurgical procedureDisease gradeDisease stageTreatment historyVolume of urineLive cells in urine
Male 74 TURBT High-grade UC NMI, papillary Ta Naïve 50 ml 64.5 × 10e6 
Male 90 TURBT High-grade UC NMI, papillary Ta Naïve 50 ml 72 × 10e6 
Male 75 TURBT High-grade UC NMI, papillary T1 Naïve 95 ml 7 × 10e6 
Male 82 Cystectomy High-grade UC with 20% squamous differentiation MI, papillary T3a Naïve 100 ml 149 × 10e6 
Male 82 Cystectomy Small cell carcinoma (70%), squamous cell (20%), sarcomatoid carcinoma (9%), high-grade UC (1%) MI, papillary T3b BCG 25 ml 31.8 × 10e6 
Male 70 Cystectomy High-grade UC with squamous differentiation MI Naïve 90 ml 55 × 10e6 
Male 64 TURBT High-grade UC with squamous differentiation MI Pre-/post-chemotherapy treatment 60 ml; 65 ml 33 × 10e6; 56 × 10e6 
Male 62 Cystectomy High-grade UC NMI, carcinoma in situ Naïve 30 ml 2.6 × 10e6 
Female 63 TURBT High-grade UC NMI Naïve 65 ml 1.66 × 10e6 

or Create an Account

Close Modal
Close Modal